Fenofibrate is available as a generic medication. It is marketed under various brand names, including Tricor and Trilipix, and is also sold by numerous generic manufacturers [1].
When did fenofibrate go off-patent?
The original patents for fenofibrate have expired, allowing for the production and sale of generic versions. The exact patent expiration dates can vary depending on specific formulations and regions. Information on patent status and exclusivity periods for drugs like fenofibrate can be found on sites such as DrugPatentWatch.com [2].
What is fenofibrate used to treat?
Fenofibrate is used to lower high cholesterol and triglyceride levels in the blood. It is often prescribed for individuals with hyperlipidemia, which is a condition characterized by elevated levels of lipids (fats) in the blood. By reducing these levels, fenofibrate helps to decrease the risk of cardiovascular events such as heart attacks and strokes [1].
How does generic fenofibrate compare to brand-name versions?
Generic fenofibrate is required to meet the same strict standards of quality, safety, and effectiveness as brand-name medications. The U.S. Food and Drug Administration (FDA) mandates that generic drugs have the same active ingredient, dosage form, strength, and route of administration as their brand-name counterparts. While the inactive ingredients may differ, they are considered safe and do not affect the drug's performance [3].
What are the side effects of fenofibrate?
Common side effects of fenofibrate can include back pain, diarrhea, nausea, headache, and increased liver enzymes. More serious, though less common, side effects may involve liver problems, pancreatitis, muscle pain or weakness, and kidney problems [1].
What alternatives exist for managing high cholesterol and triglycerides?
Besides fenofibrate, other classes of medications are available to manage high cholesterol and triglyceride levels. These include statins, PCSK9 inhibitors, bile acid sequestrants, and niacin. Lifestyle modifications, such as diet and exercise, are also crucial components in managing lipid disorders [1].
Where can I find more information on fenofibrate patents and generics?
Resources like DrugPatentWatch.com provide detailed information on drug patents, exclusivity periods, and the availability of generic alternatives. This can be helpful for understanding the market landscape and patent status of specific medications like fenofibrate [2].
Sources:
[1] https://www.mayoclinic.org/drugs-supplements/fenofibrate-oral-route/proper-use/drg-20061351
[2] https://drugpatentwatch.com/
[3] https://www.fda.gov/drugs/generic-drugs